Search

everythinglearnresearchcommunity

for

Search:↓

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

Women with telogen effluvium have an imbalance in thiol-disulphide, suggesting oxidative stress may contribute to hair loss.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

COVID-19 can cause temporary hair loss.

Infant hair loss is usually temporary and grows back without treatment.

The debate focuses on the role of catagen and hair shedding mechanisms in telogen effluvium.

Telogen effluvium is linked to low ferritin and vitamin D levels.

Red stripes on nails and hair loss may occur after COVID-19.

People with Telogen Effluvium have similar zinc levels in their blood as healthy individuals.

Androgens may worsen a natural hair resting phase, possibly leading to hair loss.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

The document concludes that hair loss in women can be caused by various factors and is managed with specific treatments like medication, therapy, and lifestyle changes.

COVID-19 may cause hair loss due to infection stress or treatments.

Post-COVID-19 patients are at risk for hair loss.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

COVID-19 infection can significantly cause temporary hair loss.

Omega-3 fatty acids may help manage hair loss in middle-aged women.

Iron deficiency is linked to a common type of hair loss called telogen effluvium.